Comment by alephnil

Already 20 years ago, medical corporations had facilities to scan millions of molecules as potential drugs candidates. This did use knowledge found manually over the years and vast computing resources. This already found more good candidates than what could be clinically tested. To find drug candidates is not remotely the bottleneck in drug development, so unless the candidates are vastly higher quality, nothing is gained.